Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-21
    E.g., 2018-06-21

Articles

12157 items
7:09 AM, Jun 04, 2018  |  BC Extra | Financial News

Enyo aims for Phase II HBV, NASH trials with €40M round

Enyo Pharma S.A. (Lyon, France) raised €40 million ($46.8 million) in a series B round led by OrbiMed Advisors. New investors Andera Partners (formerly Edmond de Rothschild Investment Partners) and Bpifrance Large Venture also participated,...
3:19 PM, Jun 01, 2018  |  BC Extra | Financial News

mRNA company Translate seeking $115M IPO

mRNA therapeutics company Translate Bio Inc. (Lexington, Mass.) proposed to raise $115 million in an IPO on NASDAQ underwritten by Citigroup, Leerink and Evercore ISI. Last month, the company began enrolling cystic fibrosis patients in a...
10:41 AM, Jun 01, 2018  |  BC Extra | Financial News

Cancer play Xynomic raises series B

Xynomic Pharmaceuticals Inc. (Dover, Del.) raised an undisclosed amount in a series B round led by Northern Light Venture Capital, Zhongshan Bison Healthcare Investment and Hakim Unique Internet Co. All of the company's existing investors,...
7:36 AM, Jun 01, 2018  |  BC Extra | Financial News

Vericel raises $65M in upsized follow-on

Cell therapy developer Vericel Corp. (NASDAQ:VCEL) raised $65 million through the sale of 5 million shares at $13 in a follow-on underwritten by Leerink, BTIG and Ladenburg Thalmann. The price is a 7% discount from Vericel's...
4:15 PM, May 31, 2018  |  BC Extra | Financial News

Neon proposes $115M IPO

Neoantigen play Neon Therapeutics Inc. (Cambridge, Mass.) proposed Thursday to raise $115 million in an IPO on NASDAQ underwritten by Morgan Stanley, BofA Merrill Lynch, Mizuho and Oppenheimer. Neon’s lead program, personalized neoantigen vaccine NEO-PV-01,...
5:31 AM, May 31, 2018  |  BC Extra | Financial News

CAMP4 Therapeutics launches with $30M series A

CAMP4 Therapeutics Corp. (Cambridge, Mass.) launched with an untranched $30 million series A round led by new investor Andreessen Horowitz. Existing investors The Kraft Group and Polaris Partners also participated. A CAMP4 spokesperson told BioCentury that...
5:02 AM, May 31, 2018  |  BC Extra | Financial News

Sequoia leads Cortexyme's $76M series B

Alzheimer’s disease company Cortexyme Inc. (South San Francisco, Calif.) raised $76 million in a series B round led by Sequoia Capital. Fellow new investors included Vulcan Capital, Verily Life Sciences LLC (South San Francisco, Calif.), EPIQ...
9:45 AM, May 30, 2018  |  BC Extra | Financial News

JHL raises $106M in bond deal

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised $106 million in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Also participating were Ruihua Investment, existing investor Milestone Capital...
2:21 PM, May 29, 2018  |  BC Extra | Financial News

Loncar to launch China BioPharma ETF

Loncar Investments LLC aims to create the Loncar China BioPharma ETF on NASDAQ, according to an SEC filing. The ETF would be based on the Loncar China BioPharma Index (LCHINA), which was unveiled in March as...
11:53 AM, May 29, 2018  |  BC Extra | Financial News

Lion raises $20M series A

Lion TCR Pte. Ltd. (Singapore) raised $20 million in a series A round from undisclosed existing investors and new investors, including Yashang Capital and Westlake Ventures Capital. The company is developing LioCyx, an autologous T cell...

Pages